NHS primary care trust

Aquis Stock Exchange: Updated Application for Admission Announcement

Retrieved on: 
Tuesday, October 17, 2023

Jeffrey has extensive experience as a non-executive director in the commercial, public and voluntary sectors, including as joint chairman of eight NHS Primary Care Trusts.

Key Points: 
  • Jeffrey has extensive experience as a non-executive director in the commercial, public and voluntary sectors, including as joint chairman of eight NHS Primary Care Trusts.
  • Kevin is the CEO of Adsure Services PLC with over 17 years’ experience in internal audit, risk management and governance in a variety of sectors.
  • NAME OF AQUIS CORPORATE ADVISER:
    NUMBER, CLASS AND PAR VALUE OF SECURITIES TO BE ADMITTED:
    10,582,440 Ordinary Shares with a par value of £0.005 per share.
  • SHAREHOLDERS HOLDING MORE THAN FIVE PER CENT OF THE APPLICANT’S SHARE CAPITAL OR VOTING RIGHTS PRE- AND POST-ADMISSION:

Aquis Stock Exchange: Application for Admission Announcement

Retrieved on: 
Monday, October 2, 2023

Jeffrey has extensive experience as a non-executive director in the commercial, public and voluntary sectors, including as joint chairman of eight NHS Primary Care Trusts.

Key Points: 
  • Jeffrey has extensive experience as a non-executive director in the commercial, public and voluntary sectors, including as joint chairman of eight NHS Primary Care Trusts.
  • Kevin is the CEO of Adsure Services PLC with over 17 years’ experience in internal audit, risk management and governance in a variety of sectors.
  • NAME OF AQUIS CORPORATE ADVISER:
    NUMBER, CLASS AND PAR VALUE OF SECURITIES TO BE ADMITTED:
    10,582,440 Ordinary Shares with a par value of £0.005 per share.
  • SHAREHOLDERS HOLDING MORE THAN FIVE PER CENT OF THE APPLICANT’S SHARE CAPITAL OR VOTING RIGHTS PRE- AND POST-ADMISSION:

Willog Partners with GBD Chile to Expand Cold Chain Monitoring Solutions in South America

Retrieved on: 
Wednesday, October 12, 2022

SEOUL, South Korea, Oct. 12, 2022 /PRNewswire/ -- Willog, a leading cold chain monitoring solution provider, announced a strategic partnership with GBD Chile , a solution distributor in the agricultural and fruit sector in Chile.

Key Points: 
  • SEOUL, South Korea, Oct. 12, 2022 /PRNewswire/ -- Willog, a leading cold chain monitoring solution provider, announced a strategic partnership with GBD Chile , a solution distributor in the agricultural and fruit sector in Chile.
  • We're very excited to partner with GBD Chile in delivering innovative cold chain solutions to the South American market.
  • "We're very excited to partner with GBD Chile in delivering innovative cold chain solutions to the South American market."
  • As a fast-growing startup, Willog provides a "cold chain data monitoring solution" that innovates the cold chain area, and its efforts are to create a transparent logistics flow.

American Battery Solutions Acquires the Entire IP Portfolio Developed by Battery Systems Innovator, Tiveni Inc.

Retrieved on: 
Wednesday, September 14, 2022

LAKE ORION, Mich., Sept. 14, 2022 /PRNewswire/ -- American Battery Solutions, Inc. ("ABS"), a leading developer and manufacturer of advanced battery systems for electrified mobility, announced today that it has signed a definitive agreement to acquire the complete IP portfolio of Tiveni, Inc., a battery systems innovator founded and led by original Tesla founder/CEO Martin Eberhard. The addition of Tiveni developed technologies will accelerate ABS' deployment of low-cost, energy-dense, highly-crash-tolerant EV batteries. The acquisition includes a supporting patent portfolio protecting the cost/density/safety advantages included in Tiveni's designs. Financial terms of the acquisition were not disclosed by mutual agreement.

Key Points: 
  • The addition of Tiveni developed technologies will accelerate ABS' deployment of low-cost, energy-dense, highly-crash-tolerant EV batteries.
  • "Along with our significant existing IP, this acquisition positions ABS IP portfolio at the forefront in relation to major industry players using cylindrical cell battery systems."
  • ABS designs and manufactures modular battery solutions for transportation, industrial, and commercial markets primarily in North America and Europe.
  • The team at American Battery Solutions Inc. includes some of the most recognized battery systems experts in the industry, with decades of experience in designing, developing, and manufacturing high-volume advanced battery systems.

DaVita Kidney Care Names New Chief Nursing Officer

Retrieved on: 
Thursday, September 16, 2021

DENVER, Sept. 16, 2021 /PRNewswire/ --During Nephrology Nurses Week, DaVita Kidney Care begins a new chapter for its nursing program by announcing Tina Livaudais as the kidney care provider's chief nursing officer (CNO).

Key Points: 
  • DENVER, Sept. 16, 2021 /PRNewswire/ --During Nephrology Nurses Week, DaVita Kidney Care begins a new chapter for its nursing program by announcing Tina Livaudais as the kidney care provider's chief nursing officer (CNO).
  • Livaudais began her career with DaVita in 1995 as a PCT while a student in nursing school at Louisiana State University.
  • DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally.
  • DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere.To learn more, visit DaVita.com/About .

Cybin Files Two Additional International Patent Applications in Support of the Company’s Research Phase Programs

Retrieved on: 
Thursday, August 19, 2021

The other PCT application includes claims and disclosures toward several other proprietary novel psychedelic compounds, including compounds with positive research data, meeting the Companys internal research metrics.

Key Points: 
  • The other PCT application includes claims and disclosures toward several other proprietary novel psychedelic compounds, including compounds with positive research data, meeting the Companys internal research metrics.
  • The Company believes these applications will further strengthen the CYB005 program, directed to therapy resistant psychiatric disorders, and provide compositions for further evaluation in additional future research programs.
  • These PCT applications are intended to provide broad international patent protection of key intellectual property in support of the Companys strategic objectives.
  • We appreciate the continued dedication of our team to identify and progress our research phase programs toward pre-clinical evaluation, said Doug Drysdale, CEO.

PCT LTD Announces Agenda for Shareholder Conference Call on Wednesday, September 29, 2020 at 4:30 pm EDT

Retrieved on: 
Wednesday, September 9, 2020

Highlights of the discussion include, but may not be limited to:

Key Points: 
  • Highlights of the discussion include, but may not be limited to:
    PCTs US marketing efforts of its patented Annihilyzer Infection Control System.
  • Mr. Grieco said: We are proud and extremely excited about all of the progress we have made at PCT in the last several months.
  • Dial-in instructions for the investor conference call will be announced prior to the meeting date.
  • PCT LTD ("PCTL") focuses its business on acquiring, developing and providing sustainable, environmentally safe disinfecting, cleaning and tracking technologies.

PCT International Files Plan of Reorganization

Retrieved on: 
Wednesday, June 10, 2020

PCT has the full support of its supply chain partners and lenders, allowing it to continue to serve its domestic and international customers.

Key Points: 
  • PCT has the full support of its supply chain partners and lenders, allowing it to continue to serve its domestic and international customers.
  • Additional capital contributions from shareholders are included in PCTs plan, and the plan provides for full payment of its undisputed creditors.
  • Steve Youtsey, CEO of PCT, said, This plan demonstrates that we are not about to abandon our customers or vendors.
  • PCT has served the telecom industry faithfully and well for over twenty years and this plan shows that we will continue to do so.

PCT Europe LTD Signs Distribution Agreement With UK NHS Company, Receives Additional NYC Hospital Order

Retrieved on: 
Thursday, April 16, 2020

PCT LTD (OTC Pink: PCTL) is pleased to announce new growth and expansion activities in the UK and NYC.

Key Points: 
  • PCT LTD (OTC Pink: PCTL) is pleased to announce new growth and expansion activities in the UK and NYC.
  • PCT Europe Ltd, the UK-based partner of PCT Corp, is pleased to announce they have signed an exclusive trading partnership/distributor agreement with an NHS (U.K. National Health Service) company.
  • In tandem with PCT Europe Ltd, the UK NHS company will introduce PCT technology to each NHS Hospital Trust with the intention of them rolling out PCTs unique technology and system throughout the health services 233 Trusts comprising over 600 hospitals.
  • The first PCT system has now been installed in a large NHS hospital in the north of England.

PCT LTD Receives Large Purchase Order for Recurring Sales of Fluids for Non-Medical Use and Explains Current Revenue Streams

Retrieved on: 
Wednesday, March 18, 2020

With the companys existing US EPA registration, PCT LTD has licensed a select number of companies as sub-registrants.

Key Points: 
  • With the companys existing US EPA registration, PCT LTD has licensed a select number of companies as sub-registrants.
  • Using PCTs US EPA registration, the company licenses the use or sale of its proprietary products, including fluids such as Hydrolyte and Hydrolyte generators.
  • Royalty agreements are also part of PCTs revenue model and are often, though not exclusively, negotiated on a per gallon basis with sub-registrants.
  • Having multiple revenue streams is an important focus of the companys business model, explains PCT Corp. President Bill Prince.